Provided by Tiger Trade Technology Pte. Ltd.

Amicus Therapeutics

14.30
0.0000
Pre-market: 14.300.00000.00%08:45 EST
Volume:4.30M
Turnover:61.49M
Market Cap:4.49B
PE:-312.88
High:14.30
Open:14.30
Low:14.28
Close:14.30
52wk High:14.38
52wk Low:5.51
Shares:314.00M
Float Shares:311.00M
Volume Ratio:0.41
T/O Rate:1.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0457
EPS(LYR):-0.1843
ROE:-6.87%
ROA:2.61%
PB:19.49
PE(LYR):-77.58

Loading ...

Amicus Therapeutics Unveils New Clinical Data for Galafold and Pombiliti + Opfolda in Fabry and Pompe Diseases

Reuters
·
Feb 03

Amicus Therapeutics präsentiert neue Langzeitdaten zu Galafold und Pombiliti + Opfolda

Reuters
·
Feb 03

Is It Time To Reassess Amicus Therapeutics (FOLD) After Last Year’s 48.9% Gain?

Simply Wall St.
·
Jan 30

Amicus Therapeutics: Solid Fundamentals but Limited Upside Amid BioMarin Takeover, Justifying Hold Rating

TIPRANKS
·
Jan 27

Amicus Therapeutics CEO Bradley L. Campbell Reports Disposal of Common Shares

Reuters
·
Jan 23

Amicus Therapeutics Cut to Hold From Buy by Jefferies

Dow Jones
·
Jan 22

Jefferies Downgrades Amicus Therapeutics to Hold From Buy, Adjusts Price Target to $14.50 From $16

MT Newswires Live
·
Jan 22

Amicus downgraded to Hold from Buy at Jefferies

TIPRANKS
·
Jan 22

U.S. RESEARCH ROUNDUP-Cencora, Crocs, Teledyne Technologies

Reuters
·
Jan 22

Amicus Therapeutics Inc : Jefferies Cuts to Hold From Buy; Cuts Target Price to $14.5 From $16

THOMSON REUTERS
·
Jan 22

Amicus Therapeutics Inc. Announces Date for Special Stockholders Meeting

Reuters
·
Jan 22

It’s Earnings Warning Season. How to Profit From Others’ Misery

Dow Jones
·
Jan 01

Amicus Therapeutics Cut to Market Perform From Outperform by Leerink Partners

Dow Jones
·
Dec 29, 2025

U.S. RESEARCH ROUNDUP-Expedia Group, Hasbro, Palisade Bio

Reuters
·
Dec 29, 2025

Leerink Downgrades Amicus Therapeutics to Market Perform From Outperform, Adjusts Price Target to $14.50 From $17

MT Newswires Live
·
Dec 29, 2025

Amicus Therapeutics Chief People Officer David Michael Clark Reports Sale of Common Shares

Reuters
·
Dec 24, 2025

What's Going On With BioMarin Stock On Tuesday?

Benzinga_recent_news
·
Dec 24, 2025

Amicus Therapeutics Cut to Neutral From Buy by Citigroup

Dow Jones
·
Dec 22, 2025

TD Cowen Downgrades Amicus Therapeutics to Hold From Buy, Adjusts PT to $14.50 From $20

MT Newswires Live
·
Dec 22, 2025

U.S. RESEARCH ROUNDUP-Comerica, Heico, Walmart

Reuters
·
Dec 22, 2025